Literature DB >> 16472090

DNA delivery for vaccination and therapeutics through the skin.

Marianna Foldvari1, Shawn Babiuk, Ildiko Badea.   

Abstract

Cutaneous gene therapy and DNA vaccination are potential applications of plasmid delivery methods where a gene for an antigen or a therapeutic protein is inserted in the plasmid and applied to the skin. However, the delivery of the DNA plasmid is a major challenge due to the unusual physicochemical properties of the DNA, the tissue and cellular barriers and expression difficulties. Even though the skin is the most accessible organ of the body and it is an ideal target for gene therapy, the delivery of plasmid DNA across the skin is very difficult due to the specific barrier function of the stratum corneum and the inconsistent transfection rate of keratinocytes and other epidermal cells. To date there is no gene delivery system that was shown to be optimal for cutaneous gene therapy. In order to develop an efficient non-viral delivery vehicle we need to design a system that provides the combined properties of effective DNA condensation, cutaneous permeation, cellular transfection and sufficiently sustained expression. This paper reviews the formulation approaches and delivery methods for DNA through the skin in the context of the barriers both at the tissue and cellular levels for both vaccine and gene therapy applications.

Mesh:

Substances:

Year:  2006        PMID: 16472090     DOI: 10.2174/156720106775197493

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  8 in total

1.  Cell-penetrating peptide secures an efficient endosomal escape of an intact cargo upon a brief photo-induction.

Authors:  Helin Räägel; Margot Hein; Asko Kriiska; Pille Säälik; Anders Florén; Ülo Langel; Margus Pooga
Journal:  Cell Mol Life Sci       Date:  2013-07-13       Impact factor: 9.261

Review 2.  DNA vaccines for targeting bacterial infections.

Authors:  Mariana Ingolotti; Omkar Kawalekar; Devon J Shedlock; Karuppiah Muthumani; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

Review 3.  Getting Drugs Across Biological Barriers.

Authors:  Rong Yang; Tuo Wei; Hannah Goldberg; Weiping Wang; Kathleen Cullion; Daniel S Kohane
Journal:  Adv Mater       Date:  2017-07-28       Impact factor: 30.849

Review 4.  Transdermal drug delivery.

Authors:  Mark R Prausnitz; Robert Langer
Journal:  Nat Biotechnol       Date:  2008-11       Impact factor: 54.908

5.  Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery.

Authors:  Grace Ledet; Sarala Pamujula; Valencia Walker; Shana Simon; Richard Graves; Tarun K Mandal
Journal:  Drug Dev Ind Pharm       Date:  2013-04-19       Impact factor: 3.225

6.  Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.

Authors:  Sarfraz Ahmad; Garrett Casey; Paul Sweeney; Mark Tangney; Gerald C O'Sullivan
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

Review 7.  Delivery systems for intradermal vaccination.

Authors:  Y C Kim; C Jarrahian; D Zehrung; S Mitragotri; M R Prausnitz
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

8.  Investigating Tick-borne Flaviviral-like Particles as a Delivery System for Gene Therapy.

Authors:  Anne H Neddermeyer; Kjell Hultenby; Maruthibabu Paidikondala; Ryan M Schuchman; Mehdi R M Bidokhti
Journal:  Curr Ther Res Clin Exp       Date:  2017-10-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.